195 related articles for article (PubMed ID: 30562113)
21. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy.
Friedrich FW; Wilding BR; Reischmann S; Crocini C; Lang P; Charron P; Müller OJ; McGrath MJ; Vollert I; Hansen A; Linke WA; Hengstenberg C; Bonne G; Morner S; Wichter T; Madeira H; Arbustini E; Eschenhagen T; Mitchell CA; Isnard R; Carrier L
Hum Mol Genet; 2012 Jul; 21(14):3237-54. PubMed ID: 22523091
[TBL] [Abstract][Full Text] [Related]
22. Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes.
Lim DS; Roberts R; Marian AJ
J Am Coll Cardiol; 2001 Oct; 38(4):1175-80. PubMed ID: 11583900
[TBL] [Abstract][Full Text] [Related]
23. Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy.
Timmer SA; Germans T; Götte MJ; Rüssel IK; Dijkmans PA; Lubberink M; ten Berg JM; ten Cate FJ; Lammertsma AA; Knaapen P; van Rossum AC
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):779-88. PubMed ID: 20069294
[TBL] [Abstract][Full Text] [Related]
24. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
Axelsson Raja A; Farhad H; Valente AM; Couce JP; Jefferies JL; Bundgaard H; Zahka K; Lever H; Murphy AM; Ashley E; Day SM; Sherrid MV; Shi L; Bluemke DA; Canter CE; Colan SD; Ho CY
Circulation; 2018 Aug; 138(8):782-792. PubMed ID: 29622585
[TBL] [Abstract][Full Text] [Related]
26. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
[TBL] [Abstract][Full Text] [Related]
27. Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy.
Ranjbarvaziri S; Kooiker KB; Ellenberger M; Fajardo G; Zhao M; Vander Roest AS; Woldeyes RA; Koyano TT; Fong R; Ma N; Tian L; Traber GM; Chan F; Perrino J; Reddy S; Chiu W; Wu JC; Woo JY; Ruppel KM; Spudich JA; Snyder MP; Contrepois K; Bernstein D
Circulation; 2021 Nov; 144(21):1714-1731. PubMed ID: 34672721
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
[TBL] [Abstract][Full Text] [Related]
29. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
Maron MS
J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
[TBL] [Abstract][Full Text] [Related]
30. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
[TBL] [Abstract][Full Text] [Related]
31. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
[TBL] [Abstract][Full Text] [Related]
32. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
33. Proteomic profiling of H-Ras-G12V induced hypertrophic cardiomyopathy in transgenic mice using comparative LC-MS analysis of thin fresh-frozen tissue sections.
Wei BR; Simpson RM; Johann DJ; Dwyer JE; Prieto DA; Kumar M; Ye X; Luke B; Shive HR; Webster JD; Hoover SB; Veenstra TD; Blonder J
J Proteome Res; 2012 Mar; 11(3):1561-70. PubMed ID: 22214408
[TBL] [Abstract][Full Text] [Related]
34. Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Gruner C; Chan RH; Crean A; Rakowski H; Rowin EJ; Care M; Deva D; Williams L; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Siminovitch K; Ralph-Edwards AC; Rastegar H; Maron BJ; Maron MS
Eur Heart J; 2014 Oct; 35(39):2706-13. PubMed ID: 24810389
[TBL] [Abstract][Full Text] [Related]
35. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
[TBL] [Abstract][Full Text] [Related]
36. Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
Ashrafian H; Redwood C; Blair E; Watkins H
Trends Genet; 2003 May; 19(5):263-8. PubMed ID: 12711218
[TBL] [Abstract][Full Text] [Related]
37. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
[TBL] [Abstract][Full Text] [Related]
38. Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.
Jablonowski R; Fernlund E; Aletras AH; Engblom H; Heiberg E; Liuba P; Arheden H; Carlsson M
Pediatr Cardiol; 2015 Dec; 36(8):1662-9. PubMed ID: 26066352
[TBL] [Abstract][Full Text] [Related]
39. Late Gadolinium Enhancement for Prediction of Mutation-Positive Hypertrophic Cardiomyopathy on the Basis of Panel-Wide Sequencing.
Teramoto R; Fujino N; Konno T; Nomura A; Nagata Y; Tsuda T; Tada H; Sakata K; Yamagishi M; Hayashi K; Kawashiri MA
Circ J; 2018 Mar; 82(4):1139-1148. PubMed ID: 29398688
[TBL] [Abstract][Full Text] [Related]
40. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.
Ho CY; López B; Coelho-Filho OR; Lakdawala NK; Cirino AL; Jarolim P; Kwong R; González A; Colan SD; Seidman JG; Díez J; Seidman CE
N Engl J Med; 2010 Aug; 363(6):552-63. PubMed ID: 20818890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
